These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8201244)
1. The breadth of action of the 5-HT3 receptor antagonists. Costall B Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():3-9. PubMed ID: 8201244 [TBL] [Abstract][Full Text] [Related]
2. Serotonin and psychiatric disorders. A key to new therapeutic approaches. Costall B; Naylor RJ Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395 [TBL] [Abstract][Full Text] [Related]
3. Astra Award Lecture. The psychopharmacology of 5-HT3 receptors. Costall B; Naylor RJ Pharmacol Toxicol; 1992 Dec; 71(6):401-15. PubMed ID: 1362267 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties and functions of central 5-HT3 receptors. Costall B; Naylor RJ Therapie; 1991; 46(6):437-44. PubMed ID: 1840228 [TBL] [Abstract][Full Text] [Related]
6. [Ondansetron--the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases]. Broocks A Fortschr Neurol Psychiatr; 1992 Jun; 60(6):227-36. PubMed ID: 1386589 [TBL] [Abstract][Full Text] [Related]
7. The clinical utility of pharmacological agents that act at serotonin receptors. Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495 [TBL] [Abstract][Full Text] [Related]
8. Serotonin receptors--where are they going? Leonard BE Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():7-17. PubMed ID: 8021439 [TBL] [Abstract][Full Text] [Related]
9. Serotonergic mechanisms and current and future psychiatric practice. Dubovsky SL; Thomas M J Clin Psychiatry; 1995; 56 Suppl 2():38-48. PubMed ID: 7844106 [TBL] [Abstract][Full Text] [Related]